Study Finds BMI and Type 2 Diabetes Independently Increase Arterial Stiffness

A cross-sectional study shows that type 2 diabetes and body mass index independently worsen arterial stiffness, with BMI having a greater impact. No synergy was found between the two risk factors.

A new study published in Diabetes, Metabolic Syndrome and Obesity reports that type 2 diabetes (T2DM) and body mass index (BMI) both independently contribute to increased arterial stiffness, with BMI accounting for the majority of vascular impairment. The cross-sectional analysis of 255 Chinese adults found no synergistic interaction between the two conditions, suggesting their effects on the arteries are additive rather than multiplicative.

The retrospective, matched cross-sectional study enrolled 255 participants: 129 with T2DM and 126 matched controls without diabetes. Controls were matched based on age (±5 years), sex, and BMI category. T2DM was diagnosed according to World Health Organization criteria, and participants with T2DM were classified into three BMI-based categories: lean (BMI <25 kg/m², n=48), overweight (BMI 25–29.9 kg/m², n=44), and obese (BMI ≥30 kg/m², n=37). Carotid intima-media thickness (IMT) and pulse wave velocity (PWV) were measured using ultrasound imaging.

Compared to the diabetes-free group, those with T2DM had significantly greater IMT and PWV (P<0.001). Among people with T2DM, an increasing BMI category was associated with progressive increases in IMT and PWV (P<0.001). Multivariable analysis revealed that BMI category was strongly associated with carotid IMT (standardized β 0.715, 95% CI: 113.4–174.7) and PWV (standardized β 0.544, 95% CI: 0.81–1.73), indicating a progressive impact of BMI on arterial stiffness. No interaction was observed between T2DM and BMI (IMT: P-interaction=0.95; PWV: P-interaction=0.56), supporting independent effects.

The study concludes that T2DM and BMI have additive but non-synergistic effects on arterial stiffness, with BMI driving most of the vascular impairment. The cross-sectional design, however, precludes causal inferences. The findings underscore the clinical relevance of weight management in people with T2DM.

Related Entities

Related Articles

References

  1. Evaluation of insulin, leptin, ghrelin, and adiponectin levels in type 2 diabetic patients ... · pubmed.ncbi.nlm.nih.gov
  2. Sustained Type 2 Diabetes Remission and Metabolic Health Through Intensive Lifestyle Intervention · cureus.com
  3. Impact of Type 2 Diabetes and Body Mass Index on Arterial Stiffness: A | DMSO · dovepress.com